A/Prof Sunil Badve is a staff specialist at St. George Hospital, Sydney and Conjoint Associate Professor of Medicine at the University of New South Wales. His medical education has been at the University of Mumbai and the University of Ottawa. He also has a PhD from the University of Queensland. He is also a clinical trialist at the Australasian Kidney Trials Network and a research fellow, the George Institute for Global Health, Sydney. He is a fellow of the American Society of Nephrology.
He is a member of several working groups including the PD and Cancer Working Groups of the ANZDATA Registry and the Gout and Crystal Arthritis Network.
His primary research focus is in clinical trials, meta-analyses and epidemiology, particularly in progression of chronic kidney disease, endpoint determination of trials, and cardiovascular disease and associated mortality in chronic kidney disease. He is the lead investigator of the CKD-FIX trial, a placebo-controlled randomised trial evaluating the effect of allopurinol on the progression of chronic kidney disease. He has been involved in the design, conduct and reporting of several renal trials including the HONEYPOT, HERO, FAVOURED and IMPROVE-CKD trials. He is a recipient of two NHMRC project grants (1043203 and 1061235) as a Chief Investigator. He has published more than 80 peer-reviewed journal articles and book chapters. His h-index is 19. He has been a regular reviewer for 28 journals.